Name:Matt PavittEmail:M.Pavitt@rbht.nhs.uk, Principal investigator Name: Selvy RajuEmail: S.Raju@rbht.nhs.uk, Study Name: Dr Duncan MacraeEmail: D.Macrae@rbht.nhs.uk, Study Name:Sally MeahEmail:sally.meah@imperial.ac.uk, Study Study contact information Find Providers by Condition. Evaluating Outpatient Video Consultations in Heart Failure: Clinician and Patient Perspectives. Name:Yousuf SalmasiEmail:M.Salmasi@rbht.nhs.uk, Principal investigator Your destination for buying luxury property in Voiron, Auvergne-Rhne-Alpes, France. Narrow or blocked arteries. Name:Dr Arvind SinghalEmail:A.Singhal@rbht.nhs.uk, Study An open-label extension trial to assess the long term safety of nintedanib in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD), Study contact information Dr VasileiosPanoulas. Name:Professor Jane DaviesEmail:J.Davies@rbht.nhs.uk. His practice is broad and covers a variety of congenital disorders including connective . Dr Rodney Franklin, Study Name: Eleanor MorrisEmail: e.morris@rbht.nhs.uk, Study Professor Martin Cowie, Study Name:Natalie Dormand (Royal Brompton), Paula Rogers (Harefield)Email:N.Dormand@rbht.nhs.uk, p.rogers@rbht.nhs.uk, Study Name:Lisa JonesEmail:l.jones2@rbht.nhs.uk, Study Name:Mr Andreas HoschtitzkyEmail:A.Hoschtitzky@rbht.nhs.uk, Principal investigator Rhythm or rate control for CRT: the RHYTHMIC study, Study Diagnosis severity & prognosis evaluation using cardiothoracic CT & MR, Study contact information Study Lung nodule Imaging Biobank for Radiomics and AI research (LIBRA), Study contact information Study contact information Six Month Mortality in Patients with COVID-19 and Non-COVID-19 - PubMed Dr Philip Molyneaux, Study Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes, Study contact information The Effects of Planned Intravenous Antibiotics on Activity and Sleep Quality in Cystic Fibrosis During the Post COVID-19 Lockdown Period, Study contact information Study contact information A randomised pragmatic trial of corticosteroid optimisation in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care, Study contact information Professor Jane Davies. Study Study contact information Study contact informationName: Abigail WatsonEmail: a.watson2@rbht.nhs.uk. As well as developing new treatments and procedures, they teach, lecture and publish articles around the world. Study 44 Boulevard Becquart Castelbon, Voiron, Auvergne-Rhne-Alpes 38500 +33 4 76 65 99 60 . A medical pioneer who founded Charing Cross Hospital. Study Name: Nicky MurrayEmail:N.Murray@rbht.nhs.uk, Study A phase 2, double-blind, randomised, placebo-controlled, two-treatment, two-period crossover efficacy and safety study in Idiopathic Pulmonary Fibrosis (IPF)with Nalbuphine ER tablets for the treatment of cough. Study Study contact information Study contact information Study Study Utility of Emphasis-10 in Risk Stratification in Pulmonary Arterial Hypertension. Development of Cardiovascular Magnetic Resonance (CMR) sequences for future clinical use, Study contact information Study Co-Design of a Pulmonary Rehabilitation intervention to Improve outcomes post-Exacerbation in Bronchiectasis, Study contact information Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis A RandomisEd ControlLed Study of PnEumRx Endobronchial Coil System Versus Standard-of-Care Medical MAnagement in the Treatment of Subjects with Severe Emphysema (ELEVATE) A Postmarket Surveillance Study (PMS). Name:Matthew JohnsonEmail:M.Johnson@rbht.nhs.uk, Study Dr Nicoletta Zimbler, Study A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension, Study 4D Flow Cardiovascular Magnetic Resonance analysis of the right ventricle in lung transplant assessment, Study contact information Narratives of NHS nurses working in ICUs during the COVID-19 pandemic, Study contact information Professor Eric Lim, Study Randomised investigation of the Mitraclip device in heart failure: 2nd trial in patients with clinically significant functional mitral regurgitation, Study contact information Name:Dr Anand DevarajEmail:a.devaraj@rbht.nhs.uk, Study Clustering and Phenotyping Interstitial Lung Disease, Study contact information Relationship between patient phenotypes and exacerbations in chronic obstructive pulmonary disease, Study contact information Name: Professor John PepperEmail: j.pepper@rbht.nhs.uk, Study A collaboration of the United Kingdom National Foetal Cardiology Working Group. Quantitive analysis of the 4-dimensional motion of the ascending aorta, Study contact information Study contact information A Phase 3, 2-Arm, open-label study to evaluate the safety and pharmacodynamics of long-term Ivacaftor treatment in subjects with Cystic Fibrosis who are less than 24 Months of age at treatment initiation and have a CFTR gating mutation, Study contact information Study COVID-19 antibody responses in Cystic Fibrosis patients, Study contact information National cohort study of Idiopathic and Heritable Pulmonary Arterial Hypertension, Study contact information Exploration of a novel mathematical approach -Symmetric Projection Attractor Reconstruction (SPAR), to assist with clinical decision making in critically ill children. WHO ISARIC Clinical Characterisation Protocol for Severe Emerging Infection UK (CCP-UK) / Novel Coronavirus Observational Study, Study contact information An evaluation of the benefits of a single dose of Simvastatin given to potential organ donors declared dead by neurological criteria on outcomes in organ recipients, Study contact information Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction (PiCSO-AMI-I), Study contact informationName: Paula RogersEmail:p.rogers@rbht.nhs.uk, Study Name:Professor Piers DaubeneyEmail:P.Daubeney@rbht.nhs.uk, Principal investigator Name:Sandra ScottEmail:s.scott@rbht.nhs.uk. A randomized, double-blind, dose-ranging, placebo-controlled Phase 2a evaluation of the safety, tolerability and pharmacokinetics of PLN-74809 in participants with idiopathic pulmonary fibrosis (IPF). Liste des Hpitaux en Saint-Marcellin, Auvergne-Rhne-Alpes . A Phase 2 Study of Efficacy and Safety of AX-8 in Chronic Cough. Study A Multicentre, Single-arm, Phase 3b Efficacy and Safety Study of Tezepelumab 210 mg Administered Subcutaneously to Reduce Oral Corticosteroid Use in Adult Participants with Severe Asthma on High-dose Inhaled Corticosteroid plus Long-acting 2 Agonist, Study contact information A Phase 3, Randomized, Double-blind, Placebo-controlled study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate-and High-risk PAH Patients. The gut microbiome in rheumatoid arthritis and bronchiectasis, Study contact information Development and validation of a method for measurement of tacrolimus, ciclosporin, and creatinine in whole blood via 2D turboflow HPLC coupled with tandem mass spectrometry, using VAMS micro sampling techniques. A molecular toolkit for the microbial investigation of severe community acquired pneumonia (S-CAP Study), Study contact information Name:Dr Justin GarnerEmail:J.Garner@rbht.nhs.uk, Study Asthma Atrial fibrillation Bronchiectasis Cancer Chronic cough Chronic Obstructive Pulmonary Disease (COPD) Chronic respiratory disease Congenital heart disease Cystic fibrosis Eisenmenger syndrome Genetics Heart failure Idiopathic pulmonary fibrosis Imaging Intensive care Interstitial Lung Disease Kawasaki disease Lung cancer Myocardial infarction Embolization coil systems: RETRACTA and HILAL, Study contact informationName: Dr Carole RidgeEmail: c.ridge@rbht.nhs.uk. Clinical Outcomes With Novel Modifier Therapy Combinations in CF, Study Dr Matthew O'Connor. Dr Elizabeth Renzoni. Dr Julene S Carvalho, Study An observational study of neurodevelopmental outcome after cardiac arrest in children admitted to paediatric intensive care, Study contact information Myocarditis is a disease heart muscle caused by inflammation. Name:Dr Lydia SpurrEmail:L.Spurr@rbht.nhs.uk, Study A Phase 3, Multi-Center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of CK3773274 in Adults with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction, Study contact information Advanced Search. A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial, Study contact information Dr Ciara Bucciarelli-Ducchi, Study Name: Dr Brian HallidayEmail: B.Halliday@rbht.nhs.uk, Study Name: Dr Ley Taing ChanEmail: l.chan3@rbht.nhs.uk, Study Benjamin E. Garfield | MediFind Dr Vasilis Kouranos, Study Professor David Firmin, Study Study contact information Study contact information Pulmonary hypertension in congenital heart disease, Study contact informationName: Dr Andrew ConstantineEmail: a.constantine@rbht.nhs.uk, Principal investigator Name:Deirdre FlanneryEmail:D.Flannery@rbht.nhs.uk, Study A Phase 2 study of ABBV-3067 alone and in combination with ABBV-2222 in Cystic Fibrosis subjects who are homozygous for the F508del mutation. Name:Alma IacobEmail:A.Iacob@rbht.nhs.uk, Principal investigator National Validation and Sensitivity to Change of a scale to measure quality of life in patients with severe asthma. Court'ea CRDITS voiron . Study United Kingdom. FFRCT In Stable Heart disease & CTA Helps Improve Patient care and Societal costs, Study contact information Name: Abigail WatsonEmail: a.watson2@rbht.nhs.uk. Study Singing for Health: Improving Experience of Lung Disease, Study contact information Study Ms Lynda Shaughnessy, Study Royal Brompton & Harefield Hospitals Specialist Care | London - Facebook Name:Sarah CollinsEmail:s.collins@rbht.nhs.uk, Study Metatranscriptomics in Non-Tuberculous Mycobacterial Pulmonary Disease, Study contact information Project Fizzyo: Remote monitoring and gaming technology for improving physiotherapy prescription, adherence and prediction of clinical outcomes in children with cystic fibrosis. Fluctuation of airway function in children with asthma phenotype as a predictor of outcome, Study Details of all our active research studies which are looking for volunteers, with more information about what each project entails and what kind of volunteers would be most suitable. Name:Angela GallagherEmail:a.gallagher2@rbht.nhs.uk, Principal investigator Severe Paediatric Asthma Collaborative in Europe (SPACE). Exploring the lived experience of being diagnosed with genetically confirmed Familial Hypercholesterolaemia in childhood, Study contact information Study contact informationName: Dr Matthew O'ConnorEmail: Principal investigator Utilising novel dipole density capabilities to objectively visualize the etiology of recurrent atrial fibrillation following a failed AF ablation, Study contact information BronchUK: Clinimetric properties of outcome measures in bronchiectasis in the UK, Study The HarEfield Acute MyocaRdial InfarcTion Cohort, Study contact informationName:Laura BarkerEmail:L.Barker2@rbht.nhs.uk, Study Benjamin Garfield practices in London, United Kingdom. Study Study A Randomised controlled trial to Assess the Safety and Efficiency of a self-Contained sampling device /disposable bronchoscope system versus usual sAmpLing procedure. Use of MRI in the assessment of cystic fibrosis and primary ciliary dyskinesia - A clinical feasibility study, Study contact information Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Heart Failure with Reduced Ejection Fraction, Study contact information Name: Dr Anand TanaEmail: a.tana@rbht.nhs.uk, Study Study contact information Benjamin E. Garfield. Ben Garfield's research works | Royal Brompton and Harefield NHS Study contact information A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF), Study contact information Incidence and Pathogenesis of Invasive Aspergillosis in Intensive Care Patients with Severe Influenza (AspiFLu), Study contact information Name:Dr Samantha IrvingEmail:S.Irving@rbht.nhs.uk, Principal investigator Study Study contact informationName: Dr John WortEmail:S.Wort@rbht.nhs.uk. A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib, 150 mg twice daily for 52 weeks (with follow up until last patient out up to a maximum of 2 years) in patients with systemic sclerosis associated interstitial lung disease, Study contact information Name: Dr Christopher OrtonEmail:c.orton@rbht.nhs.uk, Study Nasal Allergen Challenge: standardisation for house dust mite and silver birch allergen extracts, Study Effect of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock, Study contact informationName: Alcida BucajEmail: A.Bucaj@rbht.nhs.uk, Study Efficacy of domiciliary non-invasive ventilation in patients with respiratory failure due to non-CF bronchiectasis, Study contact information Name:Dr Zhe WuEmail:Z.Wu@rbht.nhs.uk, Principal investigator Name:Maria NunezEmail: M.Nunez@rbht.nhs.uk, Principal investigator A Phase 2, Multi-Centre, Open-Label, Single-Arm Trial Investigating the Safety, Efficacy and Pharmacokinetics of C21 in Subjects with Idiopathic Pulmonary Fibrosis, Study contact informationName: Victor JardimEmail: V.Jardim@rbht.nhs.uk, Study Iron and Chronic Obstructive Pulmonary Disease (COPD) exercise trial, Study contact information Name:Dr Sandra ScottEmail: s.scott@rbht.nhs.uk. A study of single doses to evaluate the safety, tolerability, pharmacokinetics and target engagement of nebulised GSK3008348 in Idiopathic Pulmonary Fibrosis patients, using positron emission tomography (PET) imaging, Study contact information Primary culture of human skeletal muscle cells from patients with conditions impairing muscle mitochondrial oxidative metabolism and causing muscle atrophy to investigate underlying molecular mechanisms of reduced oxidative metabolism and atrophy and potential novel therapies. Dr James Darius-Armstrong, Study Name:Dr Ciara MahonEmail:C.Mahon@rbht.nhs.uk, Study Study Name:Dr Claire HoggEmail:c.hogg@rbht.nhs.uk, Study What are common reasons for patients to see Dr. Benjamin C. Tam? Name:Cai SimEmail:c.sim@rbht.nhs.uk, Principal investigator Non-invasive detection of Pseudomonas aeruginosa lower airway infection in patients with Cystic Fibrosis, Study contact information Study Perspectives On Screening and early Treatment for Pulmonary Fibrosis: a qualitative study, Study contact informationName: Dr Elizabeth RenzoniEmail: e.renzoni@rbht.nhs.uk. Name: Victor JardimEmail: v.jardim@rbht.nhs.uk, Study Name:Professor Pallav ShahEmail:P.Shah@rbht.nhs.uk. Study A randomised controlled trial to investigate the effectiveness of Thoracic Epidural and Paravertebral Blockade in reducing Chronic Post-Thoracotomy Pain: 2, Study contact informationName: Dr Nandor MarczinEmail: N.Marczin@rbht.nhs.uk, Study Investigation of the molecular and cellular pathogenesis of bone marrow failure syndromes, Study contact information Benjamin Garfield is a Clinical Research Fellow in the Critical Care and Pulmonary Hypetension, Respiratory and Skeletal Muscle and Muscle Gene Expression research groups, National Heart and Lung Institute. BAROSTIM NEO - Baroreflex Activation Therapy for Heart Failure, Study contact information A drug utilization study (DUS) of alirocumab in Europe to assess the effectiveness of the dosing recommendation to avoid very low LDL-C levels. Study Name:Paolo ParediEmail:P.Paredi@rbht.nhs.uk. A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP). Name:Huw EllisEmail:Huw.Ellis@rbht.nhs.uk, Study Study contact information Name:Professor Sanjay PrasadEmail:S.Prasad@rbht.nhs.uk, Principal investigator Name:Professor Michael LoebingerEmail:M.Loebinger@rbht.nhs.uk. Name:Brian HallidayEmail:B.Halliday@rbht.nhs.uk, Study Targets of bronchial thermoplasty in severe asthma, Study contact information Homepage | Royal Brompton & Harefield hospitals BG. Sedation also poses a risk to patients with PH. Name: James TonkinEmail: j.tonkin@rbht.nhs.uk, Principal investigator Dr Andrew Menzies-Gow, Study Find out more. A phase 1, open-label, single-dose, non-randomised study to evaluate pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients, Study contact information Study Principal investigator A prospective, multicentre, randomised, blinded study of obstructive sleep apnoea detection using the Sunrise solution: The Sunrise OSA Trial (SOSAT), Study contact information Prevalence of Pompes disease amongst patients with unexplained respiratory muscle weakness or respiratory failure, Study contact information Patients Perception of Dry Powder Inhaler Airflow Resistance, Study contact information 21+. A Study to Evaluate the Feasibility and Safety of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation, Study contact informationName: Debra DempsterEmail: D.Dempster@rbht.nhs.uk, Study Clinical investigation of the VytronUS Ablation System for Treatment of Symptomatic Drug-refractory Paroxysmal Atrial Fibrillation (VITAL), Study contact informationName: Dr Tom WongEmail: T.Wong2@rbht.nhs.uk. Genetics of susceptibility and mortality in critical care, Study contact informationName:Natalie Dormand (Royal Brompton), Paula Rogers (Harefield)Email:N.Dormand@rbht.nhs.uk, p.rogers@rbht.nhs.uk, Study Name:Professor AnandDevarajEmail:A.Devaraj@rbht.nhs.uk, Principal investigator A multicentre, randomised, double-blind, placebo-controlled study in participants with sarcoidosis-associated pulmonary hypertension (SAPH) to assess the efficacy and safety of oral selexipag, Study contact informationName: Silvia ZagaloEmail: S.Zagalo@rbht.nhs.uk, Principal investigator A Phase 3b, randomised, placebo-controlled study evaluating the efficacy and safety of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis subjects 6-11 years of age who are heterozygous for the F508del mutation and a minimal function mutation (F/MF), Study contact information Dr Melissa Sanchez. A Basic Science Study of Optimised Temporary Pacing in Patients following Cardiac Surgery in Order to Build a Pacing Simulator and Automatic Alerting Algorithm. Study Name:Darshan BrahmbhattEmail:d.brahmbhatt@rbht.nhs.uk, Study Dr. Benjamin Tam, MD - Alhambra, CA | Orthopaedic Surgery National Study of prenatally diagnosed right aortic arch and double arch: Incidence; associations and outcomes. Name:Professor Susanna PriceEmail: s.price@rbht.nhs.uk, Principal investigator The measurement of transmural myocardial perfusion in normal subjects and patients with hypertension, hypertrophic cardiomyopathy (HCM) and HCM phenocopies with Cardiovascular Magnetic Resonance (CMR), Study contact information Use of pulmonary arterial hypertension therapies in Fontan patients. A Multicenter, Randomised, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis (IM027-040), Study contact informationName:Natalie DwyerEmail:N.Dwyer@rbht.nhs.uk, Study Contrast Echocardiography in VV-ECMO-Dependent Patients with - PubMed Utility of cardiopulmonary exercise testing and stress echocardiography in the assessment of breathlessness following pulmonary embolism: a pilot study, Study Name:Marina NicholasEmail:m.nicholas@rbht.nhs.uk, Principal investigator DARS-NIC-144568-D7G6V, Study contact informationName:Amrit LotaEmail:A.Lota@rbht.nhs.uk. Study Dr Samantha Irving, Study Dr Benjamin Golding - Brompton Cemetery - The Royal Parks Study Study contact informationName: Natalie DormandEmail:N.Dormand@rbht.nhs.uk, Study Name: Peter JungEmail: p.jung@rbht.nhs.uk, Study Study contact informationName: Melissa RochonEmail: m.rochon@rbht.nhs.uk, Principal investigator Name:Olga ArchangelidiEmail:o.archangelidi@rbht.nhs.uk, Study The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): a randomised placebo-controlled multi-centre clinical trial, Study Name: Dr Ali VazirEmail: a.vazir@rbht.nhs.uk, Study Name:Dr Rodney FranklinEmail:r.franklin@rbht.nhs.uk, Principal investigator Investigating management of lung nodules, and the impact of pre-diagnostic surveillance on health and economic outcomes, Study Mr Philip Molyneaux, Study Dr Nicholas Hopkinson, Study Caroline Bleakley 1 , Rosie Smith 2 , Benjamin Garfield 3 , Timothy Jackson 2 , Chris Remmington 4 , Brijesh V Patel 3 , Susanna Price 1 Affiliations 1 Department of Cardiology, Royal Brompton Hospital, London, United Kingdom; Department of Adult Critical Care, Royal Brompton Hospital, London, United Kingdom. A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease with Chronic Bronchitis, Study contact information
Brentwood Academy Basketball,
Waterfront Homes For Sale In Dighton, Ma,
What Time Do Carbone Reservations Open On Resy,
Cleveland Housing Network Houses For Rent,
Articles D